INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 427m ago
HOUSE PTR27m ago
SEC 13F27m ago
ROBINHOOD CHAIN27m ago
Corporate insider
NS

Neervannan Seshadri

Chief Operating OfficerCIK 0001827584

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 4
Max Insider Score42
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
27
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale · 10b5-1 plan
SELL$388K
4,564 sh
Sep 4, 2026Sep 9, 2026
traded Sep 4, 2026
+5dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Tarsus Pharmaceuticals, Inc.Chief Operating Officer · Dec 18, 2025
39
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL
$217K
3,125 sh
Mar 17, 2026
Mar 19, 2026
traded Mar 17, 2026
+2d
SEC FORM 4

Evidence

35
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$248K
3,610 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC FORM 4

Evidence

42
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$307K
4,589 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC FORM 4

Evidence

12
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Gift
G—
950 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

12
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Gift
G—
475 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence